CANADIAN GUIDELINES FOR THE DEVELOPMENT OF ANTIDEMENTIA THERAPIES - ACONCEPTUAL SUMMARY

The magnitude of the problems faced by Canadian society as a result of an aging population has been identified, Perhaps the most important c oncern related to this greying of Canada is the increasing incidence o f dementia and Alzheimer's disease, Therapeutic options for these diso rders have been limited to date, Advances in biotechnology and molecul ar biology will offer novel approaches to treatment. These and the exp ansion of more traditional therapeutic avenues require guidelines with the aim of optimizing their development.